SEC Info - Johnson & Johnson - ‘8-K/A’ for 4/16/24

SEC Info℠

Home

Help

Please Sign In

Johnson & Johnson – ‘8-K/A’ for 4/16/24

On: Tuesday, 4/16/24, at 12:16pm ET · For: 4/16/24 · Accession #: 200406-24-36 · File #: 1-03215

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/16/24  Johnson & Johnson                 8-K/A:9     4/16/24   12:359K

Amendment to Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     33K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML     63K 
 7: R1          Cover                                               HTML     57K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
12: XML         XBRL Instance -- jnj-20240416_htm                    XML     25K 
 8: EXCEL       IDEA Workbook of Financial Report Info              XLSX      8K 
 4: EX-101.DEF  XBRL Definitions -- jnj-20240416_def                 XML     43K 
 5: EX-101.LAB  XBRL Labels -- jnj-20240416_lab                      XML     86K 
 6: EX-101.PRE  XBRL Presentations -- jnj-20240416_pre               XML     44K 
 3: EX-101.SCH  XBRL Schema -- jnj-20240416                          XSD     14K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               15±    21K 
11: ZIP         XBRL Zipped Folder -- 0000200406-24-000036-xbrl      Zip     30K

‘8-K/A’ — Amendment to Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

jnj-20240416

i 0000200406 i false00002004062024-04-162024-04-160000200406us-gaap:CommonStockMember2024-04-162024-04-160000200406jnj:A0.650NotesDue2024Member2024-04-162024-04-160000200406jnj:A5.50NotesDue2024Member2024-04-162024-04-160000200406jnj:A1.150NotesDue2028Member2024-04-162024-04-160000200406jnj:A1.650NotesDue2035Member2024-04-162024-04-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM i 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported):

i April 16, 2024

i Johnson & Johnson

(Exact name of registrant as specified in its charter)


i New Jersey	i 1-3215	i 22-1024240
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

i One Johnson & Johnson Plaza, i New Brunswick, i New Jersey i 08933

(Address of Principal Executive Offices)

(Zip Code)

Registrant's telephone number, including area code:

i 732- i 524-0400

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17

CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17

CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
i Common Stock, Par Value $1.00	i JNJ	i New York Stock Exchange
i 0.650% Notes Due May 2024	i JNJ24C	i New York Stock Exchange
i 5.50% Notes Due November 2024	i JNJ24BP	i New York Stock Exchange
i 1.150% Notes Due November 2028	i JNJ28	i New York Stock Exchange
i 1.650% Notes Due May 2035	i JNJ35	i New York Stock Exchange

EXPLANATORY NOTE

This Amendment No. 1 to Form 8-K (“Amendment No. 1”) amends and supplements the Form 8-K filed by Johnson & Johnson on April 16, 2024 (the “Initial Form 8-K”) solely to correct a typographical error of the full-year April 2024 guidance midpoint for operational sales from $88.0 to $88.9 in the press release attached as Exhibit 99.1 to the Initial Form 8-K. A copy of the correct press release is furnished herewith as Exhibit 99.1 to this Amendment No. 1. Other than as set forth in this Amendment No. 1, no changes have been made to the Initial Form 8-K.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits.


Exhibit No.			Description of Exhibit
99.1			Press Release dated April 16, 2024 for the period ended March 31, 202 4
104			The cover page from this Current Report on Form 8-K/A, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Johnson & Johnson

(Registrant)

Date:

April 16, 2024

By:

/s/ Robert J. Decker, Jr.

Robert J. Decker, Jr.
Controller
(Principal Accounting Officer)